Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$33,015.00
Sep 9, 2025
For-profit organization
AB Validation inc.-2025-2026-1036996
1036996
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Research and Development (R&D) partnerships between the Recipient and foreign organizations in order to support R&D on the Recipient’s technology and advance its commercialization.
$254,199.00
Dec 9, 2024
For-profit organization
AAV packaging cell line generation.
1024275
The project aims to further develop the D19 clone into a user-friendly cell line for producing AAV vectors, enhancing supply for laboratories working on AAV-based gene therapies. The D19 cell line was generated by NRC from suspension and serum-free media-adapted HEK293SF cells. Using lentiviral vectors, this parental cell line was modified to integrate into its genome a gene expression regulation system induced by the addition of cumate and coumermycin to express AAV Rep proteins (Rep40 and Rep68). Three of the best clones produced AAV titers comparable to those obtained by standard triple plasmid transfection of their parental cells. Anticipated outcomes include expanding AAV production capacity, enhancing market position, generating revenue for further technology development, achieving a breakthrough in AAV bioproduction by reducing costs and streamlining industrial scaling, and strengthening Canada’s biomanufacturing capabilities in gene therapies to enhance autonomy in high-value pharmaceuticals
$31,155.00
Oct 1, 2023
For-profit organization
IP Assist L3: Intellectual Property Strategy Engagement
1010253
The project will support development of intellectual property capacity within the firm.
$7,500.00
Sep 19, 2022
For-profit organization
IP Assist – L2 : Intellectual Property Strategy Engagement
995438
The project will fund the development of the firm's intellectual property capacity
$22,500.00
Sep 19, 2022
For-profit organization
IP Assist – L3: Intellectual Property Strategy Engagement
995440
The project will fund the development of the firm's intellectual property capacity
$75,000.00
Jun 1, 2022
For-profit organization
ARP – Development of a neutralizing antibody detection kit to accelerate the development of vaccines and immunotherapies.
990628
Development of a neutralizing antibody detection kit to accelerate the development of vaccines and immunotherapies.
$50,000.00
Jul 1, 2021
For-profit organization
ARP Feasibility - Development of a detection kit for neutralization molecules
974775
Development of artificial cells and viruses to design a safe and easy-to-use tool to rapidly detect the presence of molecules that neutralize viral infections.